FOXP3 and systemic lupus erythematosus: The parallel decrease and increase of CD4+CD25-Foxp3+ T cells with the disease activity in SLE patients with renal manifestation might reflect the potential of CD4+CD25-Foxp3+ T cells as a biomarker to diagnose and monitor SLE patients with active kidney involvement.